Senores Pharmaceuticals Limited (NSE:SENORES)

Market Cap	23.71B
Revenue (ttm)	4.18B
Net Income (ttm)	585.60M
Shares Out	46.05M
EPS (ttm)	16.12
PE Ratio	31.94
Forward PE	19.07
Dividend	n/a
Ex-Dividend Date	n/a

Volume	646
Average Volume	29,142
Open	515.35
Previous Close	515.10
Day's Range	513.05 - 522.35
52-Week Range	440.00 - 664.00
Beta	n/a
RSI	47.78
Earnings Date	May 15, 2025

About Senores Pharmaceuticals

Senores Pharmaceuticals Limited develops, manufactures, and sells, pharmaceutical products in India, the United States, Canada, and internationally. The company offers tablets, capsules, liquids, dry syrups, oral rehydration solutions, active pharmaceutical ingredients, and critical care injectables, including antibiotics, anti-bacterial, anti-fungal, and blood line. It also exports its products. The company provides consulting and licensing services. Senores Pharmaceuticals Limited was incorporated in 2017 and is based in Ahmedabad, India.

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 2017
• Employees: 113
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SENORES

Financial Performance

In 2024, Senores Pharmaceuticals's revenue was 4.18 billion, an increase of 94.62% compared to the previous year's 2.15 billion. Earnings were 585.60 million, an increase of 86.17%.